Search research articles
Contact Us
Filters
Showing results (131-140 of 226) with videos related to
Page
of 23
Sort By:
Arthritis and Rheumatism
|
May 25, 2010
Glucocorticoid-induced leucine zipper is an endogenous antiinflammatory mediator in arthritis
Elaine Beaulieu, Devi Ngo, Leilani Santos, et al.
Frontiers in Immunology
|
June 23, 2018
Analysis of Serum Interleukin (IL)-1β and IL-18 in Systemic Lupus Erythematosus
Rachel Mende, Fabien B Vincent, Rangi Kandane-Rathnayake, et al.
Rheumatology (Oxford, England)
|
February 29, 2020
Attainment of treat-to-target endpoints in SLE patients with high disease activity in the atacicept phase 2b ADDRESS II study
Eric F Morand, David A Isenberg, Daniel J Wallace, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 26, 2012
Deficiency of annexin A1 in CD4+ T cells exacerbates T cell-dependent inflammation
Yuan H Yang, Wuqi Song, James A Deane, et al.
Modern Rheumatology
|
February 8, 2022
The efficacy and safety of anifrolumab in Japanese patients with systemic lupus erythematosus: TULIP-2 subanalysis
Yoshiya Tanaka, Tatsuya Atsumi, Masato Okada, et al.
Clinical & Translational Immunology
|
December 15, 2018
Analysis of serum macrophage migration inhibitory factor and D-dopachrome tautomerase in systemic sclerosis
Fabien B Vincent, Emily Lin, Joanne Sahhar, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 4, 2006
Macrophage migration inhibitory factor deficiency attenuates macrophage recruitment, glomerulonephritis, and lethality in MRL/lpr mice
Alberta Y Hoi, Michael J Hickey, Pamela Hall, et al.
Rheumatology and Therapy
|
June 7, 2024
Correction: Targeting DORIS Remission and LLDAS in SLE: A Review
Agner R Parra Sánchez, Ronald F van Vollenhoven, Eric F Morand, et al.
Rheumatology and Therapy
|
October 5, 2023
Targeting DORIS Remission and LLDAS in SLE: A Review
Agner R Parra Sánchez, Ronald F van Vollenhoven, Eric F Morand, et al.
Cytokine
|
February 4, 2015
Macrophage migration inhibitory factor is essential for osteoclastogenic mechanisms in vitro and in vivo mouse model of arthritis
Ran Gu, Leilani L Santos, Devi Ngo, et al.
Page
of 23
Search research articles
Search
Showing results (131-140 of 226) with videos related to
Sort By:
Page
of 23
Arthritis and Rheumatism
|
May 25, 2010
Glucocorticoid-induced leucine zipper is an endogenous antiinflammatory mediator in arthritis
Elaine Beaulieu, Devi Ngo, Leilani Santos, et al.
Frontiers in Immunology
|
June 23, 2018
Analysis of Serum Interleukin (IL)-1β and IL-18 in Systemic Lupus Erythematosus
Rachel Mende, Fabien B Vincent, Rangi Kandane-Rathnayake, et al.
Rheumatology (Oxford, England)
|
February 29, 2020
Attainment of treat-to-target endpoints in SLE patients with high disease activity in the atacicept phase 2b ADDRESS II study
Eric F Morand, David A Isenberg, Daniel J Wallace, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 26, 2012
Deficiency of annexin A1 in CD4+ T cells exacerbates T cell-dependent inflammation
Yuan H Yang, Wuqi Song, James A Deane, et al.
Modern Rheumatology
|
February 8, 2022
The efficacy and safety of anifrolumab in Japanese patients with systemic lupus erythematosus: TULIP-2 subanalysis
Yoshiya Tanaka, Tatsuya Atsumi, Masato Okada, et al.
Clinical & Translational Immunology
|
December 15, 2018
Analysis of serum macrophage migration inhibitory factor and D-dopachrome tautomerase in systemic sclerosis
Fabien B Vincent, Emily Lin, Joanne Sahhar, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 4, 2006
Macrophage migration inhibitory factor deficiency attenuates macrophage recruitment, glomerulonephritis, and lethality in MRL/lpr mice
Alberta Y Hoi, Michael J Hickey, Pamela Hall, et al.
Rheumatology and Therapy
|
June 7, 2024
Correction: Targeting DORIS Remission and LLDAS in SLE: A Review
Agner R Parra Sánchez, Ronald F van Vollenhoven, Eric F Morand, et al.
Rheumatology and Therapy
|
October 5, 2023
Targeting DORIS Remission and LLDAS in SLE: A Review
Agner R Parra Sánchez, Ronald F van Vollenhoven, Eric F Morand, et al.
Cytokine
|
February 4, 2015
Macrophage migration inhibitory factor is essential for osteoclastogenic mechanisms in vitro and in vivo mouse model of arthritis
Ran Gu, Leilani L Santos, Devi Ngo, et al.
Page
of 23